首页> 外文期刊>Genetic testing and molecular biomarkers >Plasminogen Activator Inhibitor Type-1 Gene 4G/5G Polymorphism in Turkish Adult Patients with Asthma
【24h】

Plasminogen Activator Inhibitor Type-1 Gene 4G/5G Polymorphism in Turkish Adult Patients with Asthma

机译:纤溶酶原激活物抑制剂1型基因4 g / 5 g多态性在土耳其成人患者哮喘

获取原文
获取原文并翻译 | 示例
           

摘要

This study has been performed on asthmatic patients in the Turkish population to determine the frequency of 4G/5G polymorphism genotypes of plasminogen activator inhibitor type-1 gene, and with the aim of ex-amining the role of this polymorphism in asthma development. Methods: Genomic DNA obtained from 165 persons (98 patients with asthma and 67 healthy controls) was used in the study. DNA was multiplied with polymerase chain reaction using 4G and 5G allele-specific primers. Polymerase chain reaction products were assessed with CCD camera by being exposed to 2% agarose gel electrophoresis. Results were evaluated with chi-square test. Results: No statistically significant difference between the groups with respect to genotype distri-bution was found (p > 0.05) in the study. The 4G allele frequency was indicated as 48% and 5G allele was as 52% in patients, whereas this was 50-50% in the control group. Conclusion: It has been established by this study that 4G/5G polymorphism genotypes of plasminogen activator inhibitor type-1 gene do not play a role in the development of asthma in the Turkish population.
机译:这项研究已经进行哮喘病人在土耳其人口决定4 g / 5 g多态性基因型的频率纤溶酶原激活物抑制剂1型基因,目的是ex-amining的角色多态性在哮喘的发展。从165人(98年获得的基因组DNA哮喘患者和67名健康对照组)在这项研究中使用。聚合酶链反应使用4 g和5克allele-specific引物。反应产物进行评估与CCD相机被暴露在2%琼脂糖凝胶电泳。卡方检验。团体之间的显著差异对基因型distri-bution被发现(p >0.05)的研究。表示48%和5 g等位基因是52%病人,而这是50 - 50%的控制组。这项研究,4 g / 5 g多态性基因型纤溶酶原激活物抑制剂1型基因不是在哮喘的发展中发挥作用土耳其人口。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号